CARDIOLOGY

A Randomized Controlled Trial Comparing Different Programming Strategies of Left Bundle Branch Area Pacing on Left Atrial Volume and Atrial High-Rate Episodes in Patients With Sinus Node Dysfunction

Aug 8, 2026 by in CARDIOLOGY Comments Off on A Randomized Controlled Trial Comparing Different Programming Strategies of Left Bundle Branch Area Pacing on Left Atrial Volume and Atrial High-Rate Episodes in Patients With Sinus Node Dysfunction
Left bundle branch area pacing (LBBAP) is a physiological pacing modality that preserves ventricular synchrony. In patients with sinus node dysfunction, who frequently exhibit delayed intrinsic atrioventricular conduction, the optimal…
read more

Limus- Versus Paclitaxel-Coated Balloons for In-Stent Restenosis Treatment: A Systematic Review and Study-Level Meta-Analysis of Randomized Controlled Trials

Aug 8, 2026 by in CARDIOLOGY Comments Off on Limus- Versus Paclitaxel-Coated Balloons for In-Stent Restenosis Treatment: A Systematic Review and Study-Level Meta-Analysis of Randomized Controlled Trials
Drug-coated balloons are the preferred treatment for in-stent restenosis (ISR), avoiding the need for a second metallic layer. While both paclitaxel-coated balloons (PCB) and limus-coated balloons (LCB, typically sirolimus or…
read more

Utilization and Outcomes of Dual Antiplatelet Therapy in Patients With Active Cancer Presenting With Acute Myocardial Infarction: A Global Registry Study

Aug 8, 2026 by in CARDIOLOGY Comments Off on Utilization and Outcomes of Dual Antiplatelet Therapy in Patients With Active Cancer Presenting With Acute Myocardial Infarction: A Global Registry Study
Individuals with cancer have an elevated risk of mortality following acute myocardial infarction (AMI), yet selecting optimal dual antiplatelet therapy (DAPT) is challenging due to competing risks of thrombosis and…
read more

Sirolimus-Coated Balloon With Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

Aug 8, 2026 by in CARDIOLOGY Comments Off on Sirolimus-Coated Balloon With Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease
Sirolimus-coated balloons (SCB) have been recently introduced for percutaneous coronary intervention (PCI). Nonetheless, evidence on the comparison of different SCB is scant. We aim to compare clinical outcomes after percutaneous…
read more

Beyond Percutaneous Coronary Intervention – Targeted Molecular Therapies for the Next Era of Coronary Care

Aug 8, 2026 by in CARDIOLOGY Comments Off on Beyond Percutaneous Coronary Intervention – Targeted Molecular Therapies for the Next Era of Coronary Care
Highlights • Pharmacological revascularization targets the underlying molecular and inflammatory disease. • Multi-omics, imaging, and artificial intelligence allow precise personalized risk assessment. • Emerging molecular target therapies stabilize vulnerable plaques…
read more

Impact of Adherence to the Global Algorithm for Initial Crossing Strategy Selection in Chronic Total Occlusion Percutaneous Coronary Intervention

Aug 8, 2026 by in CARDIOLOGY Comments Off on Impact of Adherence to the Global Algorithm for Initial Crossing Strategy Selection in Chronic Total Occlusion Percutaneous Coronary Intervention
The global chronic total occlusion (CTO) crossing algorithm was developed by experts to improve CTO percutaneous coronary intervention (PCI) outcomes but has yet to be validated using real-world data. To…
read more

Percutaneous Device Closure of Perimembranous Ventricular Septal Defect (VSD) in Congenitally Corrected Transposition of Great Arteries (cc-TGA): A Rare Case Report

Aug 8, 2026 by in CARDIOLOGY Comments Off on Percutaneous Device Closure of Perimembranous Ventricular Septal Defect (VSD) in Congenitally Corrected Transposition of Great Arteries (cc-TGA): A Rare Case Report
Highlights • Transcatheter closure of PM-VSD in cc-TGA anatomy is extremely rare and infrequently reported. • Mal-alignment of the interventricular and interatrial septum and conduction abnormalities are major hurdles in…
read more

Immediate Aspirin Discontinuation Following Percutaneous Coronary Intervention for Acute Coronary Syndromes

Aug 8, 2026 by in CARDIOLOGY Comments Off on Immediate Aspirin Discontinuation Following Percutaneous Coronary Intervention for Acute Coronary Syndromes
Dual antiplatelet therapy (DAPT) with a potent P2Y12 inhibitor and aspirin remains the standard post-PCI (percutaneous coronary intervention) antithrombotic regimen in patients presenting with acute coronary syndrome (ACS). However, safety…
read more

Right Ventricular Reverse Remodeling After Percutaneous Atrial Septal Defect Closure: A 3D Echocardiographic Assessment of Tricuspid Valve Apparatus and RV Volumetric Parameters

Aug 8, 2026 by in CARDIOLOGY Comments Off on Right Ventricular Reverse Remodeling After Percutaneous Atrial Septal Defect Closure: A 3D Echocardiographic Assessment of Tricuspid Valve Apparatus and RV Volumetric Parameters
Atrial septal defect (ASD) is a common congenital cardiac lesion that results in chronic right ventricular (RV) volume overload, leading to progressive RV dilatation, functional impairment, tricuspid annular enlargement, and…
read more
Get Clinical Tree app for offline access